Each filer's latest filing for 517954103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Westlake BioPartners Fund I, L.P.
13G
|
19.9% |
10/29/2026
Event 9/30/2026
|
||
| Westlake BioPartners Fund I, L.P. | 9.0% | |||
| Westlake BioPartners GP I, LLC | 9.0% | |||
| Westlake BioPartners Fund II, L.P. | 7.8% | |||
| Westlake BioPartners GP II, LLC | 7.8% | |||
| Westlake BioPartners Opportunity Fund I, L.P. | 3.2% | |||
| Westlake BioPartners Opportunity GP I, LLC | 3.2% | |||
| Dr. Beth C. Seidenberg | 19.9% | |||
|
Foresite Capital Fund VI LP
13D
|
14.5% |
8/17/2026
Event 8/10/2026
|
||
| Foresite Capital Fund VI LP | 3.5% | |||
| Foresite Capital Management VI, LLC | 3.5% | |||
| Foresite Capital Fund V, L.P. | 5.6% | |||
| Foresite Capital Management V, LLC | 5.6% | |||
| Foresite Capital Opportunity Fund V, L.P. | 5.4% | |||
| Foresite Capital Opportunity Management V, LLC | 5.4% | |||
| James B. Tananbaum | 14.5% | |||
|
5AM Ventures VI, L.P.
13G
|
11.0% |
11/16/2026
Event 9/30/2026
|
||
| 5AM Ventures VI, L.P. | 7.5% | |||
| 5AM Partners VI, LLC | 7.5% | |||
| 5AM Opportunities II, L.P. | 3.5% | |||
| 5AM Opportunities II (GP), LLC | 3.5% | |||
| Kush Parmar | 11.0% | |||
| Andrew J. Schwab | 11.0% | |||
|
RA Capital Management, L.P.
13G
|
8.4% |
8/17/2026
Event 8/10/2026
|
||
| RA Capital Management, L.P. | 8.4% | |||
| Peter Kolchinsky | 8.4% | |||
| Rajeev Shah | 8.4% | |||
| RA Capital Healthcare Fund, L.P. | 8.4% | |||
|
Deep Track Capital, LP
13G
|
7.0% |
8/13/2026
Event 8/7/2026
|
||
| Deep Track Capital, LP | 7.0% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 7.0% | |||
| David Kroin | 7.0% | |||
| Blue Owl Capital Holdings LP 13G | 5.4% |
11/13/2026
Event 9/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
AI Biotechnology LLC
13G/A
|
4.8% |
11/6/2026
Event 9/3/2026
|
||
| AI Biotechnology LLC | 4.8% | |||
| Access Industries Holdings LLC | 4.8% | |||
| Access Industries Management, LLC | 4.8% | |||
| Len Blavatnik | 4.8% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 58 | 41.8 M | $697M |